Manufacturers Life Insurance Company, The Harmony Biosciences Holdings, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 17,241 shares of HRMY stock, worth $572,746. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,241

Previous 17,452 1.21%

Holding current value

$572,746

Previous $526,000 30.8%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$30.0 - $39.95 $6,330 - $8,429	-211 Reduced 1.21%	17,241 $688,000
Q2 2024 Aug 14, 2024	SELL	$28.81 - $33.01 $13,742 - $15,745	-477 Reduced 2.66%	17,452 $526,000
Q1 2024 May 14, 2024	BUY	$29.93 - $35.06 $42,350 - $49,609	1,415 Added 8.57%	17,929 $602,000
Q4 2023 Feb 13, 2024	SELL	$19.2 - $33.78 $10,905 - $19,187	-568 Reduced 3.33%	16,514 $533,000
Q3 2023 Nov 15, 2023	BUY	$31.89 - $39.03 $105,077 - $128,603	3,295 Added 23.9%	17,082 $559,000
Q2 2023 Aug 11, 2023	BUY	$30.5 - $37.4 $83,204 - $102,027	2,728 Added 24.67%	13,787 $485,000
Q1 2023 May 15, 2023	BUY	$30.8 - $53.92 $6,221 - $10,891	202 Added 1.83%	11,261 $367,000
Q4 2022 Aug 11, 2023	BUY	$45.4 - $60.91 $13,166 - $17,663	290 Added 2.69%	11,059 $609,000
Q4 2022 Feb 13, 2023	BUY	$45.4 - $60.91 $13,166 - $17,663	290 Added 2.69%	11,059 $609,000
Q3 2022 Aug 11, 2023	SELL	$42.06 - $55.45 $8,075 - $10,646	-192 Reduced 1.75%	10,769 $476,000
Q3 2022 Nov 03, 2022	SELL	$42.06 - $55.45 $8,075 - $10,646	-192 Reduced 1.75%	10,769 $477,000
Q2 2022 Aug 11, 2023	BUY	$33.54 - $52.15 $33,908 - $52,723	1,011 Added 10.16%	10,961 $534,000
Q2 2022 Aug 15, 2022	BUY	$33.54 - $52.15 $33,908 - $52,723	1,011 Added 10.16%	10,961 $535,000
Q1 2022 Aug 11, 2023	SELL	$33.14 - $51.13 $43,446 - $67,031	-1,311 Reduced 11.64%	9,950 $484,000
Q1 2022 May 20, 2022	SELL	$33.14 - $51.13 $67,042 - $103,435	-2,023 Reduced 16.9%	9,950 $484,000
Q4 2021 Feb 16, 2022	BUY	$34.09 - $43.91 $17,045 - $21,955	500 Added 4.36%	11,973 $511,000
Q3 2021 Nov 12, 2021	SELL	$25.68 - $38.61 $28,093 - $42,239	-1,094 Reduced 8.71%	11,473 $440,000
Q2 2021 Aug 12, 2021	BUY	$25.96 - $33.44 $326,239 - $420,240	12,567 New	12,567 $355,000

Others Institutions Holding HRMY

# of Institutions

242

Shares Held

45.2M

Call Options Held

108K

Put Options Held

49.2K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.97B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Harmony Biosciences Holdings, Inc. Transaction History